Glaxo (GSK) Rejects Unilever's $68B Bid for Consumer Business
Published on January 17, 2022
Glaxo (GSK) rejects an offer from Unilever to acquire its consumer business worth 50 billion pounds ($68 billion). However, Unilever is likely to pursue the acquisition of the business.